Artificial Disc Market to Generate Revenue Worth $3.4 Billion by 2024

  • Published: January 2018

The global artificial disc market generated the revenue of $1.0 billion in 2017, which is expected to reach $3.4 billion by 2024, at a CAGR of 18.8% during the forecast period (2018–2024).

The cervical category held the larger share in 2017 in the artificial disc market. Further, this category is expected to witness faster growth during the forecast period, owing to the increasing cases of cervical related diseases, globally.

Increasing Strategic Development Activities Is a Key Trend Observed in the Artificial Disc Market

Rising number of mergers & acquisitions among the players as a strategic activity to expand their product portfolios and global presence is the key trend observed in artificial disc market. For instance, in September 2017, NuVasive Inc. acquired Vertera Spine. The acquisition by NuVasive Inc. is a strategic decision aimed at furthering company’s commitment to pursue strategic opportunities as it builds out its advanced materials science portfolio.

Surge in Geriatric Population to Drive the Artificial Disc Market

Globally, the elderly population is increasing. According to a report published by the United Nations Department of Economic and Social Affairs (UNDESA) entitled, World Population Ageing 2015, the population of the people aged 60 years or above is growing at a high rate. Moreover, the number of people aged 60 years or over is projected to grow by 56.0% globally, that is, from 901 million in 2015 to 1.4 billion by 2030. As the elderly population is more prone to developing degenerative disc disease, the demand for artificial disc is expected to increase in the coming years.

Segmentation Analysis of Artificial Disc Market

Artificial Disc Market

  • The cervical product category on account of rising cervical disc disease is expected to witness the faster growth during the forecast period in the artificial disc market.
  • The metal-on-polymer category in terms of material is expected to hold the larger share in the artificial disc market in 2013. This can be due to the preferred usage of artificial disc made of metal-on-polymer is preferred by healthcare professionals and patients, owing to several advantages of the material.

Geographical Analysis of Artificial Disc Market

North America accounted for the largest share in the artificial disc market in 2017, followed by Europe. Together, North America and Europe are expected to hold over 80% share in the market in 2024. This can be mainly attributed to the presence of established players, growing geriatric population, and rise in number of surgical procedures in both regions.

Other geographies, which include APAC, LATAM, and MEA, also hold considerable shares in the global artificial disc market, on account of rising healthcare expenditure, growing medical tourism, and increasing healthcare expenditure in the region.

  • Japan is expected to lead the artificial disc market in the APAC region. The market growth in this category is primarily driven by high disposable income, better healthcare infrastructure, and availability of technologically advanced products.
  • Brazil is expected to witness faster growth in the market during the forecast period, owing to the increasing healthcare expenditure in the country.

Competitive Landscape of Artificial Disc Market

The artificial disc market is fragmented in nature due to the presence of small and big players, such as Johnson & Johnson, Globus Medical Inc., B. Braun Melsungen AG, Medtronic plc, NuVasive Inc., Spinal Kinetics Inc, Simplify Medical Inc., AxioMed LLC, and K2M Group Holdings Inc.

The players are taking several strategic activities to expand their product portfolio and expand their consumer base. For instance, in April 2017, NuVasive Inc. launched a new Reline Trauma portfolio as the company’s foundation to capture the growing potential in the U.S. spine trauma fixation market.

Moreover, in February 2016, NuVasive Inc. acquired Ellipse Technologies Inc. (Ellipse), a medical technology company. The acquisition is expected to expand the NuVasive Inc.’s product portfolio as Ellipse’s products are used to treat pediatric patients while NuVasive's portfolio of products are used to treat adult deformities.